Mast cell adenosine receptors function: a focus on the a3 adenosine receptor and inflammation

Noam Rudich1, Katya Ravid, Ronit Sagi-Eisenberg

  • 1Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University Tel Aviv, Israel.

Insights

Adenosine receptors on mast cells regulate inflammation. The A3 adenosine receptor (A3R) plays a key role in airway hyperresponsiveness, but its function in humans requires further investigation.

Area of Science:

  • Immunology
  • Pharmacology
  • Respiratory Medicine

Background:

  • Adenosine is a metabolite involved in inflammatory processes.
  • Adenosine inhalation causes bronchoconstriction in asthmatics and COPD patients, mediated by mast cell activation.
  • Adenosine receptors (A1, A2a, A2b, A3) have distinct roles in tissue distribution and function.

Purpose of the Study:

  • To review the role of adenosine receptors in mast cell regulation of inflammation and pathology.
  • To focus on the common and distinct functions of the A3 adenosine receptor (A3R) in rodent and human mast cells.
  • To discuss the relevance of mouse studies to human conditions.

Main Methods:

  • Literature review of studies on adenosine receptors and mast cells.
  • Analysis of data from animal models and human studies.
  • Comparative analysis of A3R function in rodent versus human mast cells.

Main Results:

  • Animal models indicate A3R is crucial for adenosine-induced mast cell hyperresponsiveness.
  • The A2b adenosine receptor also influences this response.
  • Human studies on A3R function in mast cells have yielded controversial results.

Conclusions:

  • A3R is a potential drug target for inflammatory airway diseases.
  • Differences exist in A3R function between rodent and human mast cells.
  • Further research is needed to clarify A3R's role in human mast cell-mediated inflammation.

Related Concept Videos

Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Sympathetic Signaling01:31

Sympathetic Signaling

Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...